A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 8, Pages e23310
Publisher
Public Library of Science (PLoS)
Online
2011-08-18
DOI
10.1371/journal.pone.0023310
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Virus-Like Display of a Neo-Self Antigen Reverses B Cell Anergy in a B Cell Receptor Transgenic Mouse Model
- (2014) Bryce Chackerian et al. JOURNAL OF IMMUNOLOGY
- Programming the magnitude and persistence of antibody responses with innate immunity
- (2011) Sudhir Pai Kasturi et al. NATURE
- In Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection
- (2010) Patricia M. Day et al. Cell Host & Microbe
- Cutting Edge: IL-21 and TLR Signaling Regulate Germinal Center Responses in a B Cell-Intrinsic Manner
- (2010) J. Bessa et al. JOURNAL OF IMMUNOLOGY
- Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7
- (2010) Jerri do Carmo Caldeira et al. VACCINE
- Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection
- (2009) Balasubramanyam Karanam et al. IMMUNOLOGY AND CELL BIOLOGY
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years
- (2009) Cosette M. Wheeler et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity Testing in Human Papillomavirus Virus‐Like‐Particle Vaccine Trials
- (2009) John T. Schiller et al. JOURNAL OF INFECTIOUS DISEASES
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
- (2009) Subhashini Jagu et al. JNCI-Journal of the National Cancer Institute
- Papillomavirus Prophylactic Vaccines: Established Successes, New Approaches
- (2009) M. S. Campo et al. JOURNAL OF VIROLOGY
- Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines
- (2009) C. Schellenbacher et al. JOURNAL OF VIROLOGY
- Role of Heparan Sulfate in Attachment to and Infection of the Murine Female Genital Tract by Human Papillomavirus
- (2008) K. M. Johnson et al. JOURNAL OF VIROLOGY
- Arrangement of L2 within the Papillomavirus Capsid
- (2008) C. B. Buck et al. JOURNAL OF VIROLOGY
- Mechanisms of Human Papillomavirus Type 16 Neutralization by L2 Cross-Neutralizing and L1 Type-Specific Antibodies
- (2008) P. M. Day et al. JOURNAL OF VIROLOGY
- Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2
- (2008) H. H. Alphs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search